Aspirin and Age-Related Macular Degeneration

Ophthalmology

Volumn 117, Issue 6, 2010, Pages 1279-1280

  de Jong, Paulus T V M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BETA CAROTENE; MULTIVITAMIN; PLACEBO;

CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG TOLERABILITY; HUMAN; INCIDENCE; LETTER; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; STOMACH HEMORRHAGE; VISUAL ACUITY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARDIOVASCULAR DISEASES; HEALTH PERSONNEL; HUMANS; INCIDENCE; MACULAR DEGENERATION; MEDICAL RECORDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; UNITED STATES; VISUAL ACUITY; WOMEN'S HEALTH;

EID: 77952787860     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.03.011     Document Type: Letter

References (3)

1. Christen W.G., Glynn R.J., Chew E.Y., and Buring J.E. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology 116 (2009) 2386-2392
2. Christen W.G., Glynn R.J., Ajani U.A., et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol 119 (2001) 1143-1149
3. Van Leeuwen R., Tomany S.C., Wang J.J., et al. Is medication use associated with the incidence of early age-related maculopathy?. Pooled findings from 3 continents. Ophthalmology 111 (2004) 1169-1175